Here’s a conference we can all get behind–the helpful presentation and sharing of information on HIV, HCV, and retroviruses.
From Seattle, Business Wire press release Gilead has announced that patients co-infected with HCV genotypes 1-4 and HIV can achieve a 96 Percent SVR12 Rate taking the “daily single tablet regimen Harvoni.®”
Acute HCV: Is It Still Important to Diagnose and Treat?
HCV Genotype 3: Our Next Challenge
HCV Cirrhotics With Early Decompensation
To hear or see up-to-date information from the experts, just type in HCV in the search box and stream. Podcasts of talks are also available for downloads using Apple’s iTunes. iTunes can be downloaded free to newer computers running Windows. Apps can help move files to Android phones according to an article in Android Central here: (LINK) if you don’t own an iPhone.
For more information on Harvoni, please visit HCVETS here: (LINK).